Drug company warns of contamination

WASHINGTON, Nov. 13 (UPI) -- Tiny pieces of steel, non-latex rubber and fiber-like material have been found in some medications made by Genzyme Corp., U.S. regulators say.

Genzyme reported the particle contamination in less than1 percent of the affected drugs, the Food and Drug Administration said Friday.

The medications are used to treat rare, serious and life-threatening genetic diseases, the Cambridge, Mass., biotech company said.

Intravenous administration of the contaminated drugs could cause damage to blood vessels and severe allergic reactions.

The contaminated products are marketed by Genzyme under the names Cerezyme, Fabrayzme, Myozyme, Aldurazyme and Thyrogen.